Syprine prescribing info
WebDec 5, 2024 · Syprine is a chelating (KEE-late-ing) agent. A chelating agent works by removing a heavy metal (such as lead, mercury, or copper) from the blood. Wilson's … WebClinical Policy: Trientine (Syprine) Reference Number: ERX.SPA.255 Effective Date: 12.01.18 . Last Review Date: 11.21 . Line of Business: Commercial, Medicaid . Revision Log . See . Important Reminder. at the end of this policy for important regulatory and legal information. Description Trientine (Syprine ®) is a chelating agent. FDA Approved ...
Syprine prescribing info
Did you know?
Webprescribing information for detail on switching from pencillamine or other trientine products to Cuvrior 3,000 mg/day Syprine Age ≤ 12 years: 500-750 mg/day PO in divided doses two, three, or four times daily Age > 12 years: 750-1,250 mg/day PO in divided doses two, three, or four times daily Age ≤ 12 years: 1,500 mg/day Age > 12 years: WebSYPRINE ® (trientine hydrochloride) is used to treat Wilson's disease in patients who cannot take the medication known as penicillamine. Wilson's disease is a condition where the body stores too much copper.
Webinformation. Description Trientine (Syprine®) is a chelating agent. FDA Approved Indication(s) Syprine is indicated for the treatment of patients with Wilson’s disease who … WebTrientine (Syprine, generics) is not recommended for use in individual s with RA.1 Per the prescribing information, trientine was not found to be effective in improving any clinical or …
WebJan 18, 2012 · at the end of this policy for important regulatory and legal information. Description Trientine (Syprine®) is a chelating agent. FDA Approved Indication(s) Syprine is indicated for the treatment of patients with Wilson’s disease who are intolerant of penicillamine . Limitation(s) of use: Syprine is not indicated for treatment of biliary ... WebCuprimine® (penicillamine) and Syprine® (trientine) Used in the Treatment of Wilson’s Disease, Cystinuria, and Severe, Active Rheumatoid Arthritis Approved July 2024 …
WebFOR BRAND SYPRINE REQUESTS: Documented treatment failure, serious side effects or clinical contraindication to ALL of the following: generic penicillamine tablets AND generic …
WebTrientine (Syprine, generics) is not recommended for use in individual s with RA.1 Per the prescribing information, trientine was not found to be effective in improving any clinical or biochemical parameter after 12 weeks of treatment of individuals with RA. dodger top of the park storeWebCuprimine [prescribing information]. Bridgewater, NJ: Aton Pharma. Inc. November 2015 2. Syprine [prescribing information]. Bridgewater , NJ: Valeant Pharmaceuticals North America LLC; June 2014 3. Clinical Pharmacology® Gold Standard Series [Internet database]. Tampa FL. Elsevier 2024. dodgertown llcWebSyprine (trientine) is a member of the chelating agents drug class and is commonly used for Wilson's Disease. The cost for Syprine oral capsule 250 mg is around $22,403 for a supply of 100 capsules, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. eye clinic in ras al khaimahWebSee 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. Revised: 02/2024 FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosage 2.2 Preparation and Administration 2.3 Repeat Treatment Monitoring Safety Assessment 3 DOSAGE FORMS … eye clinic in roanoke alabamaWebMay 9, 2024 · SIDE EFFECTS. Clinical experience with SYPRINE has been limited. The following adverse reactions have been reported in a clinical study in patients with Wilson's disease who were on therapy with trientine hydrochloride: iron deficiency, systemic lupus erythematosus (see CLINICAL PHARMACOLOGY).In addition, the following adverse … eye clinic in scottsbluff nebraskaWebPlease provide any changes or clarifying information for the policy below: 4Q 2024 annual review: no significant changes; references reviewed and updated. ... Syprine Prescribing Information. Bridewater, NJ: Bausch Health Companies Inc: September 2024. Available at: www.syprine.com. Accessed July 14, 2024. eye clinic in sholinganallurWebFeb 9, 2024 · Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of generic version of Syprine ®1 (trientine hydrochloride) capsules, 250 mg, in the U.S. Trientine hydrochloride is used in the treatment of patients with Wilson’s disease who are intolerant of penicillamine. dodgertown football